You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥現代(600420.SH):下屬子公司獲得藥品註冊證書
格隆匯 07-28 16:45

格隆匯7月28日丨國藥現代(600420.SH)公佈,公司下屬子公司國藥集團容生製藥有限公司(簡稱國藥容生)、國藥一心製藥有限公司(簡稱國藥一心)分別收到國家藥品監督管理局核准簽發的《藥品註冊證書》。

鹽酸咪達普利片適用於治療:1、原發性高血壓;2、腎實質性病變所致繼發性高血壓。

亞葉酸鈣注射液適用於高劑量甲氨蝶呤治療的後續治療以減少毒性(亞葉酸鈣解救),也用於治療因疏忽造成的甲氨蝶呤過量及甲氨蝶呤排泄受損的患者;與氟尿嘧啶合用,可提高氟尿嘧啶的療效,臨牀上常用於結直腸癌與胃癌的治療;也用於口炎性腹瀉、營養不良、妊娠期或嬰兒期引起的巨幼細胞性貧血,當口服葉酸療效不佳時,對維生素B12缺乏性貧血並不適用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account